NASDAQ: RIGL - Rigel Pharmaceuticals, Inc.
Доходность за полгода: +47.36%
Сектор: Healthcare
Rigel Pharmaceuticals, Inc. Форум акций| Параметр | Оценка | Значение | Среднее по сектору | Разница с сектором, % | Средняя за 5 лет | Разница со средней, % |
|---|---|---|---|---|---|---|
| P/E | -7.92 | 47.96 | -116.51% | -13.01 | -39.1% | |
P/E Forward 
|
|
-9 | -13.01 | -30.76% | ||
| P/S |
|
1.7006 | 33.73 | -94.96% | 3.8 | -55.27% |
| P/S Forward |
|
1.8275 | 3.8 | -51.93% | ||
| P/BV |
|
231.97 | 4.81 | 4725.39% | 4.86 | 4670.33% |
| P/BV Forward |
|
200.78 | 4.86 | 4028.95% | ||
| Ev/Ebitda |
|
-15.96 | -22.5 | -29.04% | -14.13 | 12.96% |
| Ev/Ebitda Forward |
|
-16.76 | -14.13 | 18.61% |
